Filed before 2025Filed 9 May 2023
Solarea Bio, Inc. raised $15M
Solarea Bio, Inc., a biotech company based in Cambridge, MA, raised $15M in a new equity round, according to a filing dated 9 May 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 9 May 2023
- Round
- Equity round
- Amount sold
- $15M
- Offering size
- $25M
- Investors so far
- 4
- Based in
- Cambridge, MA
- Website
- solareabio.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 72% of the 1,396 tracked raises with an amount filed in 2023, and than 53% of the 142 in biotech.
Solarea Bio, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 20 Nov 2025 | New filing | $9.91M | Another raise |
| 10 Sep 2024 | New filing | $1M | Another raise |
| 9 May 2023 | New filing | $15M | This raise |
| 11 Sep 2020 | New filing | $11.3M | Another raise |
More with BOLD Capital Associates on the board
- Gallant Pet, Inc.$10.2M
- Syntis Bio, Inc.$25M
- Exo Imaging, Inc.$43.9M
- Viome Life Sciences, Inc.$25.4M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.